CTKB Cytek Biosciences, Inc. - Common Stock
$4,02
Cena · Maj 22, 2026
Dane fundamentalne na dzień Maj 7, 2026
Zakres 52 tyg.
$2–$6
42% of range
Ocena Analityków
BUY
10 analysts
Cena Docelowa
$6
+41% upside
P/E (TTM)
505.0
ROE
-18.5%
Marża Zysku Netto
-33.0%
CTKB Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$4.02
Kapitalizacja Rynkowa
$649M
P/E (TTM)
505.0
EPS (TTM)
$-0.09
Przychody (TTM)
$201M
Stopa dywidendy
—
ROE
-18.5%
D/E Dług/Kapitał
—
Zakres 52 tyg.
$2 – $6
CTKB Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Configure
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody i Zysk Netto
$201M
2020-12-31
→
2025-12-31
EPS
$-0.09
2020-12-31
→
2023-12-31
Wolny przepływ pieniężny
$-9M
2021-12-31
→
2025-12-31
Marże
-33.0%
2021-12-31
→
2025-12-31
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Wskaźnik
Trend 5-letni
CTKB
Mediana porównawcza
P/E (TTM)
505.0
7.1
P/S (TTM)
3.2
3.3
P/B
1.9
1.6
Price / FCF (Cena / FCF)
-74.0
—
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Wskaźnik
Trend 5-letni
CTKB
Mediana porównawcza
Gross Margin (Marża brutto)
51.8%
48.1%
Operating Margin (Marża Operacyjna)
-20.0%
—
Net Profit Margin (Marża Zysku Netto)
-33.0%
-21.2%
ROA
-13.9%
-8.2%
ROE
-18.5%
-10.6%
ROIC
-26.4%
—
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Wskaźnik
Trend 5-letni
CTKB
Mediana porównawcza
Current Ratio (Wskaźnik bieżący)
5.0
4.9
Quick Ratio (Wskaźnik Szybkości)
2.0
—
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Wskaźnik
Trend 5-letni
CTKB
Mediana porównawcza
Revenue YoY (Przychody R/R)
0.52%
—
Revenue CAGR 3Y (Przychody CAGR 3L)
7.1%
—
Revenue CAGR 5Y (Przychody CAGR 5L)
209.5%
—
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Wskaźnik
Trend 5-letni
CTKB
Mediana porównawcza
CTKB Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
KUP
10 analityków
- Mocne kupno 3 30,0%
- Kup 4 40,0%
- Trzymaj 3 30,0%
- Sprzedaj 0 0,0%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
4 analityków · 2026-05-26
Mediana
$5.25
Średnia
$5.69
← Poniżej wszystkich celów
$4.02
Niski
$4.75
Wysoki
$7.50
Średni cel
$5.25
+30,6%
Średnia cel
$5.69
+41,5%
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
-0.01%
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 31 marca 2026 | $-0.15 | $-0.10 | -0.05% |
| 31 grudnia 2025 | $-0.04 | $-0.02 | -0.02% |
| 30 września 2025 | $-0.04 | $-0.05 | 0.01% |
| 30 czerwca 2025 | $-0.04 | $-0.07 | 0.03% |
| 31 marca 2025 | $-0.09 | $-0.05 | -0.04% |
Porównanie jednostek Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| CTKB | $649M | 505.0 | 0.52% | -33.0% | -18.5% | 51.8% |
| AZTA | $1.32B | -23.5 | 3.5% | -9.4% | -3.3% | 45.5% |
| PSNL | $816M | -8.7 | -17.7% | -116.7% | -36.0% | — |
| CYRX | $479M | 6.9 | 12.4% | 44.4% | 15.3% | 47.1% |
| MLAB | $647M | -329.6 | 11.5% | -0.82% | -1.2% | 62.6% |
| DNA | $484M | -1.5 | -25.1% | -183.8% | -55.8% | — |
| LAB | $495M | -6.4 | -6.2% | -87.8% | -17.6% | 49.9% |
| PACB | $565M | -1.0 | 3.9% | -341.5% | -1634.9% | 28.6% |
| OABI | — | — | — | — | — | — |
| NAUT | $247M | -4.1 | — | — | -34.9% | — |
| CDXS | $147M | -3.3 | 18.6% | -62.5% | -82.8% | — |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 18
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $201M | $200M | $193M | $164M | $2M | $710.0K | |
| Cost of Revenue | $97M | $89M | $84M | $63M | $49M | $41M | |
| Gross Profit | $104M | $111M | $109M | $101M | $79M | $52M | |
| R&D Expense | $36M | $39M | $44M | $35M | $24M | $14M | |
| SG&A Expense | $59M | $43M | $44M | $35M | $21M | $9M | |
| Operating Expenses | $145M | $132M | $137M | $103M | $70M | $38M | |
| Operating Income | $-40M | $-21M | $-28M | $-2M | $9M | $14M | |
| Interest Expense | · | · | $2M | $3M | $2M | $333.0K | |
| Interest Income | $2M | $5M | $6M | $5M | $49.0K | $110.0K | |
| Other Non-op | $9M | $4M | $8M | $1M | $-2M | $994.0K | |
| Pretax Income | $-30M | $-6M | $-16M | $1M | $6M | $14M | |
| Income Tax | $37M | $320.0K | $-4M | $-1M | $3M | $-5M | |
| Net Income | $-67M | $-6M | $-12M | $2M | $3M | $19M | |
| EPS (Basic) | · | · | $-0.09 | $0.02 | $0.00 | $0.11 | |
| EPS (Diluted) | · | · | $-0.09 | $0.02 | $0.00 | $0.10 | |
| Shares (Basic) | 127,745,939 | 130,611,330 | 135,283,044 | 134,510,831 | 76,741,858 | 29,126,792 | |
| Shares (Diluted) | 127,745,939 | 130,611,330 | 135,283,044 | 138,562,111 | 81,542,729 | 32,599,847 | |
| EBITDA | $-33M | $-13M | $-22M | $688.0K | $10M | · |
Bilans 26
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $91M | $99M | $167M | $297M | $365M | $165M | |
| Receivables | $63M | $61M | $56M | $49M | $30M | $17M | |
| Inventory | $48M | $44M | $61M | $48M | $32M | $23M | |
| Prepaid Expense | $20M | $14M | $13M | $13M | $5M | $2M | |
| Other Current Assets | $3M | $2M | $2M | $4M | $708.0K | $445.0K | |
| Current Assets | $392M | $396M | $392M | $454M | $432M | $209M | |
| PP&E (Net) | $18M | $18M | $18M | $14M | $6M | $2M | |
| PP&E (Gross) | $30M | $27M | $24M | $17M | $8M | $3M | |
| Accum. Depreciation | $12M | $9M | $6M | $3M | $2M | $934.0K | |
| Goodwill | $17M | $17M | $16M | $10M | $10M | $476.0K | |
| Intangibles | $17M | $20M | $23M | $4M | $5M | $274.0K | |
| Other Non-current Assets | $7M | $5M | $3M | $3M | $2M | $1M | |
| Total Assets | $462M | $500M | $494M | $519M | $463M | $220M | |
| Accounts Payable | $23M | $21M | $20M | $21M | $15M | $9M | |
| Accrued Liabilities | $23M | $21M | $20M | $21M | $15M | $9M | |
| Current Liabilities | $78M | $68M | $56M | $49M | $33M | $27M | |
| Capital Leases | $14M | $8M | $9M | $12M | $0 | · | |
| Other Non-current Liabilities | $2M | $2M | $2M | $2M | $1M | $737.0K | |
| Total Liabilities | $120M | $104M | $101M | $94M | $58M | $42M | |
| Common Stock | $129.0K | $129.0K | $131.0K | $135.0K | $126.0K | $23.0K | |
| Paid-in Capital | $441M | $431M | $423M | $443M | $424M | $6M | |
| Retained Earnings | $-102M | $-35M | $-29M | $-17M | $-20M | $-23M | |
| AOCI | $2M | $16.0K | $-1M | $-697.0K | $897.0K | $65.0K | |
| Stockholders' Equity | $342M | $396M | $393M | $426M | $405M | $-16M | |
| Liabilities + Equity | $462M | $500M | $494M | $519M | $463M | $220M | |
| Shares Outstanding | 128,550,136 | 129,205,901 | 130,714,906 | 135,365,381 | 133,749,663 | 31,241,916 |
Przepływy pieniężne 15
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $8M | $7M | $6M | $2M | $1M | $603.0K | |
| Stock-based Comp | $25M | $27M | $22M | $17M | $7M | $611.0K | |
| Deferred Tax | $34M | $-3M | $0 | $0 | $-2M | $-7M | |
| Amort. of Intangibles | $4M | $4M | $3M | $800.0K | $300.0K | $71.0K | |
| Other Non-cash | $-4M | $225.0K | $-638.0K | $-23M | $-4M | · | |
| Operating Cash Flow | $-5M | $25M | $5M | $-12M | $5M | $15M | |
| CapEx | $4M | $4M | $5M | $10M | $4M | $2M | |
| Investing Cash Flow | $10M | $-83M | $-94M | $-56M | $-21M | $-2M | |
| Stock Repurchased | $15M | $22M | $44M | $0 | $0 | · | |
| Net Stock Activity | $-15M | $-22M | $-44M | · | · | · | |
| Financing Cash Flow | $-13M | $-16M | $-42M | $6M | $214M | $123M | |
| Net Change in Cash | $-8M | $-69M | $-132M | $-65M | $198M | $136M | |
| Taxes Paid | $2M | $4M | $5M | $10M | $3M | $2M | |
| Free Cash Flow | $-9M | $22M | $633.0K | $-22M | $266.0K | · | |
| Levered FCF | · | · | $-968.5K | $-27M | $-621.5K | · |
Rentowność 8
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Gross Margin | 51.8% | 55.4% | 56.7% | 61.6% | 61.9% | · | |
| Operating Margin | -20.0% | -10.2% | -14.4% | -1.1% | 7.2% | · | |
| Net Margin | -33.0% | -3.0% | -6.3% | 1.5% | 2.4% | · | |
| Pretax Margin | -14.8% | -2.8% | -8.1% | 0.77% | 4.6% | · | |
| EBITDA Margin | -16.3% | -6.6% | -11.3% | 0.42% | 8.1% | · | |
| ROA | -13.9% | -1.2% | -2.4% | 0.51% | 0.89% | · | |
| ROE | -18.5% | -1.5% | -3.0% | 0.59% | 0.75% | · | |
| ROIC | -26.4% | -5.5% | -5.5% | -0.84% | 1.1% | · |
Płynność i wypłacalność 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 5.0 | 5.9 | 7.0 | 9.3 | 13.0 | · | |
| Quick Ratio | 2.0 | 2.4 | 4.0 | 7.0 | 11.9 | · | |
| Interest Coverage | · | · | -13.4 | -0.7 | 5.3 | · |
Efektywność 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.4 | 0.4 | 0.3 | 0.4 | · | |
| Inventory Turnover | 2.1 | 1.7 | 1.5 | 1.6 | 1.8 | · | |
| Receivables Turnover | 3.3 | 3.4 | 3.7 | 4.2 | 5.5 | · |
Stopy Wzrostu 4
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | 0.52% | 3.9% | 17.7% | 7421.1% | 207.2% | · | |
| Revenue CAGR 3Y | 7.1% | 351.3% | 547.8% | · | · | · | |
| Revenue CAGR 5Y | 209.5% | · | · | · | · | · | |
| Net Income YoY | · | · | · | -17.9% | -84.4% | · |
Wycena (TTM) 10
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $201M | $200M | $193M | $164M | $2M | · | |
| Net Income TTM | $-67M | $-6M | $-12M | $2M | $3M | · | |
| Market Cap | $649M | $839M | $1.19B | $1.38B | $2.18B | · | |
| P/E | 505.0 | 649.0 | -101.3 | 510.5 | · | · | |
| P/S | 3.2 | 4.2 | 6.2 | 8.4 | 1000.8 | · | |
| P/B | 1.9 | 2.1 | 3.0 | 3.2 | 5.4 | · | |
| P / Tangible Book | 2.1 | 2.3 | 3.4 | 3.4 | 5.6 | · | |
| P / Cash Flow | -138.5 | 33.0 | 225.7 | -113.0 | 471.4 | · | |
| P / FCF | -74.0 | 38.4 | 1883.3 | -62.9 | 8206.0 | · | |
| Earnings Yield | 0.20% | 0.15% | -0.99% | 0.20% | 0.00% | · |
Rachunek zysków i strat 18
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $44M | $62M | $52M | $46M | $41M | $57M | $52M | $47M | $45M | $58M | $48M | $50M | $37M | $48M | $40M | $40M | |
| Cost of Revenue | $23M | $29M | $25M | $22M | $21M | $24M | $22M | $21M | $22M | $25M | $21M | $22M | $16M | $19M | $14M | $16M | |
| Gross Profit | $21M | $33M | $28M | $24M | $20M | $34M | $29M | $25M | $23M | $33M | $27M | $28M | $21M | $29M | $27M | $25M | |
| R&D Expense | $10M | $9M | $9M | $9M | $10M | $10M | $10M | $10M | $10M | $11M | $11M | $12M | $10M | $10M | $9M | $8M | |
| SG&A Expense | $18M | $16M | $16M | $14M | $13M | $9M | $11M | $12M | $11M | $11M | $10M | $11M | $12M | $11M | $8M | $9M | |
| Operating Expenses | $40M | $38M | $37M | $34M | $35M | $31M | $33M | $34M | $34M | $33M | $34M | $37M | $33M | $29M | $26M | $25M | |
| Operating Income | $-18M | $-6M | $-9M | $-11M | $-15M | $3M | $-4M | $-9M | $-11M | $-136.0K | $-6M | $-9M | $-12M | $84.0K | $1M | $-891.0K | |
| Interest Expense | · | · | · | · | · | · | · | · | $441.0K | · | $595.0K | $409.0K | $673.0K | · | $649.0K | $647.0K | |
| Interest Income | $787.0K | $580.0K | $573.0K | $555.0K | $508.0K | $913.0K | $1M | $1M | $1M | $1M | $2M | $1M | $2M | $3M | $2M | $391.0K | |
| Other Non-op | $565.0K | $257.0K | $1M | $4M | $3M | $490.0K | $3M | $59.0K | $823.0K | $3M | $1M | $2M | $2M | $2M | $-445.0K | $-254.0K | |
| Pretax Income | · | $-4M | $-8M | $-7M | $-11M | $10M | $157.0K | $-7M | $-9M | $4M | $-4M | $-7M | $-9M | $4M | $2M | $-1M | |
| Income Tax | $1M | $40M | $-2M | $-1M | $136.0K | $680.0K | $-784.0K | $3M | $-3M | $-1M | $2M | $-2M | $-2M | $396.0K | $224.0K | $-699.0K | |
| Net Income | $-19M | $-44M | $-5M | $-6M | $-11M | $10M | $941.0K | $-10M | $-6M | $6M | $-6M | $-4M | $-7M | $4M | $2M | $-702.0K | |
| EPS (Basic) | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-0.01 | $0.00 | |
| EPS (Diluted) | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-0.01 | $0.00 | |
| Shares (Basic) | 128,704,934 | -255,075,695 | 127,547,859 | 126,934,294 | 128,339,481 | -262,753,871 | 131,003,744 | 131,440,486 | 130,920,971 | -272,298,135 | 136,173,278 | 135,918,707 | 135,489,194 | -268,506,452 | 134,711,701 | 134,403,059 | |
| Shares (Diluted) | 128,704,934 | -255,075,695 | 127,547,859 | 126,934,294 | 128,339,481 | -264,535,679 | 132,785,552 | 131,440,486 | 130,920,971 | -272,298,135 | 136,173,278 | 135,918,707 | 135,489,194 | -268,452,806 | 138,709,335 | 134,403,059 | |
| EBITDA | $-17M | · | $-9M | $-11M | $-13M | · | $-4M | $-9M | $-9M | · | $-6M | $-9M | $-11M | · | $1M | $-891.0K |
Bilans 26
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $66M | $91M | $93M | $75M | $95M | $99M | $162M | $178M | $169M | · | $164M | $132M | $129M | · | $342M | $350M | |
| Receivables | $52M | $63M | $57M | $56M | $55M | $61M | $53M | $45M | $50M | · | $55M | $50M | $43M | · | $40M | $37M | |
| Inventory | $50M | $48M | $52M | $49M | $45M | $44M | $47M | $50M | $55M | · | $67M | $66M | $70M | · | $49M | $45M | |
| Prepaid Expense | $15M | $20M | $18M | $15M | $15M | $14M | $13M | $12M | $13M | · | $12M | $11M | $11M | · | $13M | $11M | |
| Other Current Assets | $4M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | · | $2M | $2M | $1M | · | $2M | $1M | |
| Current Assets | $379M | $392M | $388M | $383M | $381M | $396M | $390M | $384M | $389M | · | $422M | $425M | $426M | · | $444M | $443M | |
| PP&E (Net) | $20M | $18M | $18M | $18M | $18M | $18M | $19M | $18M | $18M | · | $17M | $16M | $16M | · | $8M | $7M | |
| PP&E (Gross) | $34M | $30M | $30M | $29M | $27M | $27M | $27M | $25M | $24M | · | $22M | $20M | $19M | · | $10M | $10M | |
| Accum. Depreciation | $13M | $12M | $12M | $11M | $10M | $9M | $8M | $7M | $6M | · | $5M | $4M | $4M | · | $3M | $2M | |
| Goodwill | $17M | $17M | $17M | $17M | $17M | $17M | $16M | $16M | $16M | · | $16M | $19M | $19M | · | $10M | $10M | |
| Intangibles | $16M | $17M | $18M | $19M | $19M | $20M | $20M | $21M | $22M | · | $24M | $24M | $25M | · | $4M | $4M | |
| Other Non-current Assets | $6M | $7M | $4M | $5M | $5M | $5M | $5M | $5M | $4M | · | $3M | $3M | $3M | · | $5M | $3M | |
| Total Assets | $449M | $462M | $495M | $493M | $483M | $500M | $491M | $484M | $492M | · | $519M | $525M | $525M | · | $499M | $493M | |
| Accounts Payable | $20M | $23M | $20M | $22M | $19M | $21M | $21M | $15M | $18M | · | $21M | $20M | $20M | · | $17M | $18M | |
| Accrued Liabilities | $20M | $23M | $20M | $22M | $19M | $21M | $21M | $15M | $18M | · | $21M | $20M | $20M | · | $17M | $18M | |
| Current Liabilities | $81M | $78M | $75M | $73M | $68M | $68M | $63M | $52M | $56M | · | $59M | $54M | $57M | · | $41M | $42M | |
| Capital Leases | $13M | $14M | $13M | $14M | $7M | $8M | $8M | $8M | $9M | · | $10M | $11M | $12M | · | $14M | $12M | |
| Other Non-current Liabilities | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | · | $2M | $2M | $2M | · | $1M | $1M | |
| Total Liabilities | $121M | $120M | $116M | $116M | $103M | $104M | $106M | $95M | $99M | · | $104M | $101M | $101M | · | $83M | $82M | |
| Common Stock | $129.0K | $129.0K | $128.0K | $127.0K | $128.0K | $129.0K | $130.0K | $132.0K | $131.0K | · | $136.0K | $136.0K | $136.0K | · | $135.0K | $135.0K | |
| Paid-in Capital | $446M | $441M | $435M | $430M | $427M | $431M | $430M | $435M | $429M | · | $452M | $454M | $448M | · | $437M | $433M | |
| Retained Earnings | $-121M | $-102M | $-58M | $-52M | $-47M | $-35M | $-45M | $-46M | $-35M | · | $-35M | $-28M | $-24M | · | $-21M | $-22M | |
| AOCI | $2M | $2M | $821.0K | $-38.0K | $-609.0K | $16.0K | $101.0K | $-195.0K | $-2M | · | $-2M | $-2M | $-587.0K | · | $-530.0K | $228.0K | |
| Stockholders' Equity | $328M | $342M | $379M | $378M | $380M | $396M | $385M | $389M | $393M | · | $416M | $424M | $423M | $426M | $417M | $411M | |
| Liabilities + Equity | $449M | $462M | $495M | $493M | $483M | $500M | $491M | $484M | $492M | · | $519M | $525M | $525M | · | $499M | $493M | |
| Shares Outstanding | 129,142,587 | 128,550,136 | 127,864,830 | 127,185,113 | 127,599,142 | 129,205,901 | 129,766,011 | 131,505,201 | 131,254,181 | · | 135,545,663 | 136,344,908 | 135,644,055 | · | 134,849,139 | 134,601,671 |
Przepływy pieniężne 15
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $761.0K | $72.0K | $865.0K | |
| Stock-based Comp | $5M | $6M | $6M | $7M | $7M | $7M | $7M | $7M | $6M | $6M | $6M | $6M | $5M | $4M | $4M | $4M | |
| Deferred Tax | $-183.0K | $39M | $-3M | $-2M | $-336.0K | $-3M | $0 | $0 | $0 | · | · | · | · | · | · | · | |
| Amort. of Intangibles | $900.0K | $1M | $900.0K | $900.0K | $900.0K | $1M | $900.0K | $900.0K | $900.0K | $800.0K | $900.0K | $1M | $500.0K | $-353.0K | $200.0K | $500.0K | |
| Other Non-cash | $10M | · | · | · | $3M | · | · | · | $3M | · | · | · | $4M | · | · | · | |
| Operating Cash Flow | $-3M | $-771.0K | $-4M | $108.0K | $-125.0K | $2M | $13M | $6M | $4M | $10M | $-4M | $-3M | $3M | $6M | $-8M | $-12M | |
| CapEx | $2M | $1M | $657.0K | $2M | $849.0K | $894.0K | $1M | $1M | $567.0K | $2M | $1M | $1M | $505.0K | $7M | $1M | $1M | |
| Investing Cash Flow | $-27M | $-2M | $19M | $-16M | $9M | $-63M | $-16M | $2M | $-6M | $29M | $43M | $3M | $-169M | $-51M | $-1M | $-3M | |
| Stock Repurchased | $0 | $-34.0K | $-29.0K | $5M | $11M | $7M | $12M | $3M | $0 | $35M | · | · | · | · | · | · | |
| Net Stock Activity | $0 | · | · | · | $-11M | · | $-12M | $-3M | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $4M | $-1M | $2M | $-3M | $-12M | $-4M | $-12M | $-2M | $2M | $-34M | $-8M | $216.0K | $0 | $4M | $155.0K | $1M | |
| Net Change in Cash | $-25M | $-2M | $18M | $-20M | $-3M | $-64M | $-16M | $9M | $2M | $4M | $32M | $-850.0K | $-167M | $-42M | $-8M | $-13M | |
| Taxes Paid | $-4M | $2M | $0 | $25.0K | $0 | $2M | $864.0K | $1M | $0 | $4M | $127.0K | $590.0K | $93.0K | $460.0K | $2M | $8M | |
| Free Cash Flow | $-5M | · | · | · | $-974.0K | · | · | · | $3M | · | · | · | $2M | · | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | $3M | · | · | · | $2M | · | · | · |
Rentowność 8
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 48.2% | · | 52.7% | 52.3% | 48.6% | · | 56.3% | 54.6% | 51.3% | · | 56.6% | 56.7% | 56.7% | · | 66.4% | 61.2% | |
| Operating Margin | -41.8% | · | -17.6% | -23.3% | -36.1% | · | -8.2% | -18.3% | -23.9% | · | -13.4% | -18.4% | -32.8% | · | 3.4% | -2.2% | |
| Net Margin | -42.8% | · | -10.5% | -12.2% | -27.5% | · | 1.8% | -22.4% | -13.8% | · | -13.5% | -8.8% | -18.4% | · | 4.0% | -1.8% | |
| Pretax Margin | · | · | -14.9% | -14.9% | -27.2% | · | 0.30% | -15.4% | -20.1% | · | -8.7% | -13.3% | -24.4% | · | 4.6% | -3.5% | |
| EBITDA Margin | -37.6% | · | -17.6% | -23.3% | -31.6% | · | -8.2% | -18.3% | -20.1% | · | -13.4% | -18.4% | -30.1% | · | 3.4% | -2.2% | |
| ROA | -4.0% | · | -1.1% | -1.1% | -2.3% | · | 0.19% | -2.1% | -1.2% | · | -1.3% | -0.86% | -1.4% | · | 0.34% | -0.19% | |
| ROE | -5.3% | · | -1.4% | -1.5% | -2.9% | · | 0.23% | -2.6% | -1.5% | · | -1.6% | -1.1% | -1.6% | · | 0.40% | -0.35% | |
| ROIC | · | · | -1.7% | -2.3% | -4.0% | · | -6.6% | -3.2% | -1.9% | · | -2.4% | -1.4% | -2.2% | · | 0.29% | -0.11% |
Płynność i wypłacalność 3
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.7 | · | 5.2 | 5.2 | 5.6 | · | 6.2 | 7.3 | 7.0 | · | 7.2 | 7.9 | 7.5 | · | 10.7 | 10.5 | |
| Quick Ratio | 1.5 | · | 2.0 | 1.8 | 2.2 | · | 3.4 | 4.2 | 3.9 | · | 3.7 | 3.4 | 3.1 | · | 9.2 | 9.1 | |
| Interest Coverage | · | · | · | · | · | · | · | · | -24.3 | · | -10.8 | -22.3 | -18.1 | · | 2.1 | -1.4 |
Efektywność 3
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | |
| Inventory Turnover | 0.5 | · | 0.5 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.3 | · | 0.4 | 0.4 | |
| Receivables Turnover | 0.8 | · | 1.0 | 0.9 | 0.8 | · | 1.0 | 1.0 | 1.0 | · | 1.0 | 1.1 | 1.0 | · | 1.2 | 1.3 |
Wycena (TTM) 10
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $183M | · | $191M | $185M | $184M | · | $191M | $189M | $180M | · | $175M | $167M | $153M | · | $150M | $140M | |
| Net Income TTM | $-41M | · | $-22M | $-26M | $-27M | · | $-22M | $-27M | $-24M | · | $-16M | $-10M | $-8M | · | $186.0K | $1M | |
| Market Cap | $564M | · | $444M | $432M | $512M | · | $719M | $734M | $881M | · | $748M | $1.16B | $1.25B | · | $1.98B | $1.44B | |
| P/E | 437.0 | · | 347.0 | 340.0 | 401.0 | · | 554.0 | 558.0 | 671.0 | · | 552.0 | 854.0 | 919.0 | · | 1472.0 | 536.5 | |
| P/S | 3.1 | · | 2.3 | 2.3 | 2.8 | · | 3.8 | 3.9 | 4.9 | · | 4.3 | 7.0 | 8.2 | · | 13.2 | 10.3 | |
| P/B | 1.7 | · | 1.2 | 1.1 | 1.3 | · | 1.9 | 1.9 | 2.2 | · | 1.8 | 2.7 | 2.9 | · | 4.8 | 3.5 | |
| P / Tangible Book | 1.9 | · | 1.3 | 1.3 | 1.5 | · | 2.1 | 2.1 | 2.5 | · | 2.0 | 3.1 | 3.3 | · | 4.9 | 3.6 | |
| P / Cash Flow | -206.3 | · | · | · | -4093.4 | · | · | · | 222.6 | · | · | · | 436.2 | · | · | · | |
| P / FCF | -115.1 | · | · | · | -525.3 | · | · | · | 259.8 | · | · | · | 529.8 | · | · | · | |
| Earnings Yield | 0.23% | · | 0.29% | 0.29% | 0.25% | · | 0.18% | 0.18% | 0.15% | · | 0.18% | 0.12% | 0.11% | · | 0.07% | 0.19% |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Przychody | $201M | $200M | $193M | $164M | $2M |
| Marża Brutto % | 51.8% | 55.4% | 56.7% | 61.6% | 61.9% |
| Marża Operacyjna % | -20.0% | -10.2% | -14.4% | -1.1% | 7.2% |
| Zysk netto | $-67M | $-6M | $-12M | $2M | $3M |
| Rozwodniony EPS | — | — | $-0.09 | $0.02 | $0.00 |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wskaźnik bieżący | 5.0 | 5.9 | 7.0 | 9.3 | 13.0 |
| Wskaźnik Szybkości | 2.0 | 2.4 | 4.0 | 7.0 | 11.9 |
Przepływy pieniężne
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $-9M | $22M | $633.0K | $-22M | $266.0K |
Najnowsze wiadomości Najnowsze nagłówki wspominające o tej firmie
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
📊
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.